期刊文献+

MYH9、STAT4、uPA基因多态性与特发性膜性肾病的相关性 被引量:3

Association of MYH9,STAT4 and uPA gene single nucleotide polymorphism with idiopathic membranous nephropathy
下载PDF
导出
摘要 目的:探讨MYH9(rs12107)、STAT4(rs3024912)、uPA(rs4065)单核苷酸多态性与特发性膜性相关性。方法:2011年6月至2015年5月在新疆维吾尔自治区人民医院确诊的45例特发性膜性肾病(IMN)患者为病例组(IMN组),45例IgA肾病(IgAN)患者为疾病对照组(IgAN组),45例健康体检者为健康对照组,选取直接测序方法检测rs12107、rs3024912、rs4065位点单核苷酸多态性(SNP),分析3个位点基因型及等位基因频率与IMN相关性。结果:A组rs12107位点CC基因型、C等位基因频率(48.9%、65.6%)高于B组(13.3%、33.3%)和C组(20.0%、46.7%),差异有统计学意义(P〈0.05):C等位基因携带者患IMN的风险是T等位基因的2.18倍(95%CI1.19~3.97):单因素Logistic回归分析rs12107位点CC基因型较非CC基因型的患者发生肾功能衰竭的风险高(OR=5.56,95%CI 1.27~24.29,P=0.023);rs3024912基因型和等位基因频率在3组之间差异均无统计学意义;rs3024912位点GG基因型的患者是非GG基因型的患者发生肾功能衰竭风险的6.30倍(95%CI1.48~26.83,P=0.013);rs4065位点只有TT一种基因型,未见到TC、CC基因型。结论:MYH9基因m12107位点CC基因型和C等位基因是新疆维吾尔族IMN的易感因素,且CC基因型与肾功能相关:STAT4基因rs3024912位点GG基因型与新疆维吾尔族IMN易感性无关.但与肾功能相关。 Objective To investigate thecorrelation between nonmusle myosin heavy chain 9 gene (MYH9) rs12107, signal transducer and activator of transcription (STAT4) rs3024912, Urokinase plasminogen activator (uPA) rs4065 single nucleotide polymorphism and idiopathic Uighur membranous nephropathy (IMN). Methods Patients admittedby People's Hospital of Xinjiang Uyghur Autonomous Region from June 2011 to May 2015 were selected in the research, of which 45 with IMN (group A), 45 patients with IgA nephropathy (group B) and 45 healthy controls (group C). The polymorphisms of rs12107, rs3024912 and rs4065 were measured with direct sequencing, in order to analyzing the correlation between genotype and allele with IMN. Results Group Ars12107 (MYH9) locus genotype CC, C allele (48.9%, 65.6%) frequency were higher than those in group B (13.3%, 33.3%) and group C (20.0%, 46.7%), and the difference was statistically significance (P 〈 0.05). C allele carriers of the risk of IMN is 2.18 times that of the T allele(95% CI: 1.19-3.97). Univariate Logistic regression analysis of rs12107 CC genotype showed patients with CC genotype faced with high risk of renal failure (OR = 5.56,95% CI: 1.27-24.29, P = 0.023) compared with non-CC genotype patients, rs3024912 genotype and allele frequencies showed no significant difference among the three groups (P 〉 0.05). rs3024912 GG genotype patients showed higher risk of renal failure compared with non-GG genotype patients (95% CI: 1.48- 26.83, P = 0.013). Only TT genotype was detected on rs4065 locus. TC and CC genotype were not detected. Conclusions MYH9 gene rs12107 locus CC genotype and C allele are associated with susceptibility to IMN in Xinjiang Uygur, and CC genotypes associated with renal function, rs3024912 (STAT4)GG genotype are not susceptibility gene, but associated with renal function in patients with IMN.
出处 《实用医学杂志》 CAS 北大核心 2016年第3期376-381,共6页 The Journal of Practical Medicine
基金 国家自然基金课题(编号:81560121) 自治区"十二五"重大科技专项(编号:201230119) 新疆维吾尔自治区科技成果转化(编号:201454135)
关键词 肾小球肾炎 膜性 单核苷酸多态性 信号转导和转录激活因子4 非肌性肌球蛋白重链9 尿激酶型纤溶酶原激活物 Idiopathic membranous nephropathy Signal transducer and activator of transcription Nonmusle myosin heavy chain 9 gene Urokinase plasminogen activator Single nucleotide polymorphism
  • 相关文献

参考文献19

  • 1洪艳.特发性膜性肾病发病机制研究进展[J].实用医学杂志,2012,28(8):1379-1380. 被引量:21
  • 2GLA5SOCK RJ. The pathogenesis of membranous nephropathy:Evolution and revolution [J]. Curr Opin Nephrol Hypertens,2012,21(3):235-242.
  • 3CHEN YT, CHEN CH, TSAI FJ, et al. Association betweenMYH9 gene polymorphisms and membranous glomerulonephritispatients in Taiwan [J]. Science Asia, 2013 ,39(6) : 625-630.
  • 4CHEN CH, CHEN SY, SHU KH, et al. Urokinase gene 3-UTR T/C polymorphism is associated with malignancy andESRD in idiopathic membranous nephropathy [J], BioMed ResInt ,2014,2014(2) :425095-425102.
  • 5CHEN SY, CHEN CH, HUANG YC, et al. Effect of IL-6C- 572G polymorphism on idiopathic membranous nephropathy risk in han Chinese population [J]. Reu Fail, 2010, 32(10): 1172-1176.
  • 6COUSER WG, NANGAKU M. Cellular and molecular biologyof membranous nephropathy [J]. J Nephrol,2006,19(6) :699-705.
  • 7SINGH N,NAINANI N, ARORA P,et al. CKD in MYH9-related disorders[J].Am J Kidney Dis,2009,54(4) :732-740.
  • 8PECCI A, PANZA E,PUJOL-MOIX N, et al. Position ofnonmuscle myosin heavy chain IIA (NMMHC-IIA) Mutationspredicts the natural history of MYH9-related disease [J]. HumMutat,2008 ,29(3):409-417.
  • 9KOPP JB, SMITH MW, NELSON GW. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis [J]. NatGenet,2008,40( 10) : 1175-1184.
  • 10KAO W,KLAG MJ, MEONI LA, et al. MYH9 is associatedwith non-Diabetic end-stage renal disease in African Americans[J]. Nat Genet,2008,40(10) :1185-1192.

二级参考文献12

  • 1Kerjaschki D. Pathomechanisms and molecular basis of membranous glomerulopathy[J].The Lancet,2004,(9441):1194-1196.
  • 2Debiec H,Guigonis V,Mougenot B. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies[J].New England Journal of Medicine,2002,(26):2053-2060.
  • 3Debiec H,Nauta J,Coulet F. Role of truncating mutations in MME gene in fetomatemal alloimmunisation and antenatal glomerulopathies[J].The Lancet,2004,(9441):252-1259.
  • 4Beck L H Jr,Bonegio R G,Lambeau G. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy[J].New England Journal of Medicine,2009,(01):11-21.doi:10.1056/NEJMoa0810457.
  • 5Prunotto M,Camevali M L,Candiano G. Autoimmunity in membranous nephropathy targets aldose reductase and S0D2[J].Journal of the American Society of Nephrology,2010,(03):507-519.
  • 6Bruschi M,Camevali M L,Murtas C. Direct characterization of target podocyte antigens and autoantibodies in human membranous glomerulonephritis:alpha-enolase and borderline antigens[J].J Proteomics,2011,(10):2008-2017.
  • 7Murtas C,Bruschi M,Camevali M L. In vivo characterization of renal auto-antigens involved in human autoimmune diseases:The case of membranous glomerulonephritis[J].Proteomics Clin Appl,2011,(1-2):90-97.
  • 8Hoxha E,Harendza S,Zahner G. An immunofluorescence test for Phospholipase-A2-Receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis[J].Nephrology Dialysis Transplantation,2011,(08):2526-2532.
  • 9Hofstra J M,Beck L H Jr,Beck D M. Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy[J].Clin J Am Soc Nephrol,2011,(06):1286-1291.
  • 10Beck L H,Fervenza F C,Beck D M. Anti-PLA2r autoantibodies and response to Rituximab treatment in membranous nephropathy[J].Journal of the American Society of Nephrology,2011,(08):1543-1550.

共引文献20

同被引文献17

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部